Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance.
about
Oral substitution treatment of injecting opioid users for prevention of HIV infectionSubstitution treatment of injecting opioid users for prevention of HIV infectionSex differences in outcomes of methadone maintenance treatment for opioid addiction: a systematic review protocolPersistence of low drug treatment coverage for injection drug users in large US metropolitan areasSex differences in outcomes of methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis.Substance use and high risk sexual behaviors among women in psychosocial outpatient and methadone maintenance treatment programs.Impact of interim methadone maintenance on HIV risk behaviors.HIV risk behavior in opioid dependent adults seeking detoxification treatment: an exploratory comparison of heroin and oxycodone users.Women who use injection drugs: the social context of risk.Alcohol use and gender effects on HIV risk behaviors in cocaine-using methadone patientsPatients' Reasons for Choosing Office-based Buprenorphine: Preference for Patient-Centered Care.Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection.The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone.Methadone maintenance treatment participant retention and behavioural effectiveness in China: a systematic review and meta-analysisThe association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence.Risk factors in the relationship between gender and crack/cocaine.Impact of methadone with versus without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trialPostprison release HIV-risk behaviors in a randomized trial of methadone treatment for prisonersPreventing HIV in injection drug users: choosing the best mix of interventions for the population.Longitudinal HIV risk behavior among the Drug Abuse Treatment Outcome Studies (DATOS) adult sample.Substance abuse treatment in human immunodeficiency virus: the role of patient-provider discussions.Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.Neurocognitive and psychiatric dimensions of hot, but not cool, impulsivity predict HIV sexual risk behaviors among drug users in protracted abstinence.Behavioral factors predicting response to employment-based reinforcement of cocaine abstinence in methadone patients.A Brief Assessment for HIV Risk: The TCU HVHP Form.Longitudinal changes in sexual risk behavior among HIV+ and HIV- male injecting drug users.Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada.Sexual behaviors among methadone maintenance patients in a mountainous area in northern Vietnam.Contingency management reduces drug-related human immunodeficiency virus risk behaviors in cocaine-abusing methadone patients.Gender differences at admission and follow-up in a sample of methadone maintenance clients.Reduced injection risk and sexual risk behaviours after drug misuse treatment: results from the National Treatment Outcome Research Study.Changes in HIV risk behaviors among cocaine-using methadone patients.Treating cocaine-using methadone patients: predictors of outcomes in a psychosocial clinical trial.Drug abuse treatment and risky sex: evidence for a cumulative treatment effect?HIV sex-risk behaviors among in- versus out-of-treatment heroin-addicted adults.Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment.Understanding condom use among heroin addicts in methadone maintenance using the information-motivation-behavioral skills model.The autonomy of mood disorders among cocaine-using methadone patients.
P2860
Q24234956-F4056CED-1270-40D1-982A-920A307463D0Q24243272-F5C5B12F-66A9-412E-BE08-A935E0D2FFC6Q27024389-4E32E4B1-41C4-4B1B-BC2C-4DB18BB38BDFQ30496986-A4323094-842C-4894-A5A0-D856D358D69FQ30667111-904465A3-C463-40C4-A438-3015B391FF30Q33756780-50663829-F312-436D-9216-50E1812A2BDCQ33977272-8E8F371E-5C2A-4024-82BE-4C9657567EAEQ33999306-9039D550-D730-4C99-BB21-DCB47F79265AQ34029427-E4B58AE5-2741-44E2-8456-1DAA00002691Q34051233-13DF5330-3BD9-475F-94E0-993379DD0C83Q34408522-8F59CF89-2EB4-4741-9ACA-8FBD6F123228Q34704122-6FDDA1D7-CC6F-45F4-96F5-73BB39E78D45Q34731327-61BA842B-8684-4929-A3C6-7B7D9D374D2EQ34901860-B977B882-0BDE-45FE-A680-A0C26A25C8FEQ35023292-2C3D35E3-69B3-402D-BCCD-EA5AA89FE051Q35238023-2447444B-802D-4E02-BF0B-0A306EB83F03Q35878056-FDFCFD05-CC37-44E1-BA35-BB3238C823F4Q36174969-58D25C8A-E49B-4728-8452-2E1EB1050379Q36272465-19EF3BC0-840D-4F02-9907-26E1B8A8E8AFQ36881886-98809F7F-E2EE-4992-9500-212DA87D25E2Q36952590-F20C9489-C324-4E67-A705-BB3D53469C17Q36984354-89C81B8D-BC0B-41D4-B7FF-477724D61D09Q37114232-E0C5B9A2-5148-4A89-A000-BD7B9787B4A2Q37357865-5FD4D44E-68EA-485E-A8AC-73C5FE56A1F7Q37367517-932D8312-F20B-4649-9A9D-F5F7836209FAQ39512038-6EFB4F5B-2C2E-48D7-8498-EFD90D73436CQ40891018-BE29A8A5-7E67-4EF3-95F5-41B3993E80CFQ41541878-452C413B-533E-4542-BD31-03BCCECF5334Q42656373-C4E51734-3785-4803-AE5A-A1A372D418E9Q43603456-BB21EA45-CE15-472E-A0C6-505E57B30AE9Q43859013-D57DC220-24DB-4848-9C97-02191618F07CQ44054367-8739C92A-97AB-428E-9798-0102C30F15E8Q44268736-01E3C04A-FEC4-4C81-872E-489A8AE787C3Q46264119-4183EFA0-71B7-4611-B771-B753C24606C4Q46968533-BD199BB6-9873-407D-97B3-217607F5B5AFQ51971535-0782B175-ECA2-417A-81AF-CB3B5ED754F8Q52080434-6F29BD22-7F75-4479-8CA7-D5D5F4EA9420Q52221619-4798DD83-C51A-49B0-B65F-5727FACA3819
P2860
Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Gender, cocaine and during-tre ...... sers in methadone maintenance.
@en
Gender, cocaine and during-tre ...... sers in methadone maintenance.
@nl
type
label
Gender, cocaine and during-tre ...... sers in methadone maintenance.
@en
Gender, cocaine and during-tre ...... sers in methadone maintenance.
@nl
prefLabel
Gender, cocaine and during-tre ...... sers in methadone maintenance.
@en
Gender, cocaine and during-tre ...... sers in methadone maintenance.
@nl
P2093
P1476
Gender, cocaine and during-tre ...... sers in methadone maintenance.
@en
P2093
P356
10.1016/0376-8716(96)01235-5
P577
1996-05-01T00:00:00Z